The People’s Medicine: How Legalization Improves America’s Healthcare

Warning message

The subscription service is currently unavailable. Please try again later.

In the heart of Denver, the newly-minted marijuana capital of America, doctors from around the nation bared unseasonable late-summer frost to attend the Marijuana for Medical Professionals Conference. The event targeted medical professionals with one thing in common—a desire to know more about cannabis medicines as the substance is propelled out of the realms of early 20th-century “reefer madness” and into popular use as a highly-lucrative, 21st-century panacea.

On the top floor of the 100-year-old former Masonic temple, a cascade of doctors, a virtual “who’s who” of cannabis science, gathered in the large auditorium. Dr. Raphael Mechoulam—the Israeli researcher who isolated and identified ∆-9 tetrahydrocannabinol (THC) and cannabidiol (CBD) in the early 1960s— and Dr. Lester Grinspoon, long-time American cannabis researcher, professor emeritus in psychiatry at Harvard Medical School and author of “Marihuana Reconsidered” were among the attendees.

Over the course of the three-day conference, it became clear...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.